Open Access
ISSN:1195-9479(print)
ISSN:1488-5581(online)
Publication Frequency:Bi-monthly
The Canadian Journal of Urology (CJU) is a peer-reviewed indexed journal that is published and included in the Journal Citation Reports/Science Edition. The journal has steadily gained recognition in the medical community within Canada and abroad, and continues to successfully disseminate the latest scientific knowledge in the field of urology. We welcome the urological medical community to submit original research articles, review articles, practice updates and case reports. All submissions are peer-reviewed by the CJU's peer review board hand-picked by our editorial board, under the leadership of our Editor-in-Chief. The Canadian Journal of Urology has been published continuously since 1994. In November 2000, the journal was accepted for indexation in Index Medicus and MEDLINE. All issues from its inception to the present are archived and accessible at PubMed Central, the US National Library of Medicine's database of journals.
Science Citation Index Expanded (SCIE): 2023 Impact Factor 1.2; Scopus: Citescore 1.9 (2023), SNIP 0.426 (2023); MEDLINE/PubMed; EMBASE
Effective 2025, the Canadian Journal of Urology (CJU) will be published by Tech Science Press (TSP). This transition is designed to enhance the journal’s academic impact and global visibility while ensuring an improved publishing experience for researchers.
The journal's aims, scope, and formatting guidelines will remain unchanged. The journal's Editor-in-Chief, Prof. Leonard Gomella, and the editorial board will continue to lead the journal toward an even more successful future.
We appreciate the ongoing support of our authors, reviewers, and readers as we embark on this exciting new chapter.
Open Access
LEGENDS IN UROLOGY
Canadian Journal of Urology, Vol.32, No.1, pp. 1-3, 2025, DOI:10.32604/cju.2025.064707 - 20 March 2025
Abstract This article has no abstract. More >
Open Access
ARTICLE
Canadian Journal of Urology, Vol.32, No.1, pp. 5-13, 2025, DOI:10.32604/cju.2025.064697 - 20 March 2025
Abstract Urethral catheterization is an important skill to develop as consultations for “difficult catheterization” are common in practice. Developing a broad approach to difficult urethral catheterization is crucial to improve trainee success rates. Strategies and techniques to improve catheterization success are often passed down and shared between trainees without formal documentation or dissemination of techniques. Herein, we present a framework for difficult urethral catheterization based on clinical history and patient examination, while also providing additional techniques and troubleshooting to overcome common challenges with urethral catheterization in adult and pediatric patients. More >
Open Access
ARTICLE
Canadian Journal of Urology, Vol.32, No.1, pp. 15-19, 2025, DOI:10.32604/cju.2025.064708 - 20 March 2025
Abstract Introduction: Holmium Laser Enucleation of the Prostate (HoLEP) is a size-independent, endoscopic management option for benign prostatic hyperplasia (BPH). HoLEP offers a distinct advantage for patients who are at high-risk for bleeding whilst preserving prostatic tissue for pathology analysis, unlike photoselective vaporization. Further, HoLEP avoids the need for cystotomy, unlike simple open and robotic prostatectomy, by using intravesical morcellation. We report our experience with the first 1000 HoLEP procedures at our institution. Materials and Methods: We performed a retrospective review of all HoLEP procedures performed at our institution from 2013–2021 to capture patient demographics, procedure details,… More >
Open Access
ARTICLE
Canadian Journal of Urology, Vol.32, No.1, pp. 21-27, 2025, DOI:10.32604/cju.2025.064705 - 20 March 2025
Abstract Purpose: While the mental health impact of a prostate cancer diagnosis, including low-risk prostate cancer, is well-documented, the effect of pre-existing anxiety and/or depression on adherence to active surveillance protocols in low-risk prostate cancer patients remains unclear. This study assessed the association between prior anxiety and/or depression and active surveillance adherence in men with low-risk prostate cancer. Methods: We conducted a retrospective, multicenter study involving 426 men diagnosed with low-risk prostate cancer who were recommended active surveillance as the primary management strategy. Active surveillance adherence was defined by completion of both a prostate-specific antigen test… More >
Open Access
ARTICLE
Canadian Journal of Urology, Vol.32, No.1, pp. 29-36, 2025, DOI:10.32604/cju.2025.064710 - 20 March 2025
Abstract Introduction: Non–muscle-invasive bladder cancer (NMIBC) is a common malignancy worldwide. While Bacillus Calmette-Guérin (BCG) is standard of care for treatment for most patients with high-risk NMIBC, many will either not respond to BCG initially or will eventually develop BCG-unresponsive disease. A treatment option in BCG-unresponsive disease is nadofaragene firadenovec-vncg (Adstiladrin), a nonreplicating adenoviral vector–based gene therapy approved by the US Food and Drug Administration (FDA) for the treatment of adults with high-risk BCG-unresponsive NMIBC with carcinoma in situ with or without papillary tumors. Objective: To review safety outcomes of participants who received the FDA-approved dose… More >
Open Access
ARTICLE
Canadian Journal of Urology, Vol.32, No.1, pp. 37-42, 2025, DOI:10.32604/cju.2025.064684 - 20 March 2025
Abstract Objectives: To assess outcomes of rectourethral fistula repair utilizing a gracilis flap in a largely radiated cohort. Patients and Methods: We performed a retrospective review of all gracilis interposition flap reconstruction surgeries performed for RUF at a university hospital in South Carolina between January 2010 and June 2023. All repairs utilized a multidisciplinary approach with urology, colorectal, and plastic surgery teams. Post-operatively, patients were maximally drained with foley catheter and suprapubic tube (SPT). Initial voiding cystourethrogram (VCUG) was performed at 4 weeks post-repair. If there was a persistent leak, catheter drainage was maintained for 4 additional… More >
Open Access
CASE REPORT
Canadian Journal of Urology, Vol.32, No.1, pp. 43-46, 2025, DOI:10.32604/cju.2025.064688 - 20 March 2025
Abstract A 14-year-old presented with an asymptomatic left testicular mass after a brief episode of pain. Examination showed a non-tender left testis that was significantly larger than the right. Ultrasound revealed a 4.5-cm avascular mass and an absence of normal testicular parenchyma. Tumor markers were unremarkable. A CT scan demonstrated no lymphadenopathy but identified a prominent left spermatic cord. Due to a suspicion of chronic torsion vs. malignancy, a left radical orchiectomy was performed. Pathology identified a hemorrhagic paratesticular venous malformation without signs of germ cell neoplasia, a rare entity. More >
Open Access
CASE REPORT
Canadian Journal of Urology, Vol.32, No.1, pp. 47-53, 2025, DOI:10.32604/cju.2025.064694 - 20 March 2025
Abstract Perivascular epithelioid cell tumors (PEComas) are a diverse group of mesenchymal neoplasms. While they have been described throughout the genitourinary system, PEComas are quite rare within the bladder. We present the case of a 37-year-old male who presented in clot retention and was found to have a bladder PEComa. Staging images seemingly demonstrated solid tumor confinement to the bladder and pelvis. Intraoperative pathology revealed peritoneal metastasis. The patient underwent a pelvic mass excision and partial cystectomy. The patient had plans for adjuvant chemotherapy, but later returned to the hospital and passed away from acute hypoxic More >
Open Access
ARTICLE
Canadian Journal of Urology, Vol.32, No.1, pp. 55-62, 2025, DOI:10.32604/cju.2025.064701 - 20 March 2025
Abstract Introduction: Infections are the most feared complication of transrectal prostate biopsies, along with growing concerns of antibiotic resistance. Our institution transitioned to a transperineal approach without use of perioperative antibiotics or bowel preparations. We aimed to compare the safety outcomes associated with transperineal and transrectal prostate biopsy techniques. Materials and Methods: A retrospective analysis of patients who underwent transrectal and transperineal prostate biopsies at our institution from 2019–2022 was performed. Results: We identified 319 patients—174 transrectal and 145 transperineal. 8 patients who had transperineal biopsy (5.5%) received peri-operative antibiotics, compared to 100% with transrectal biopsy. 35.86%… More >
Open Access
ARTICLE
Canadian Journal of Urology, Vol.32, No.1, pp. 63-70, 2025, DOI:10.32604/cju.2025.064711 - 20 March 2025
Abstract Introduction: With the aging population, more females will suffer from pelvic organ prolapse. Both urologists and gynecologists perform sacrocolpopexy, but there is no comparative study analyzing differences in provision of care, outcomes, or patient population. We aimed to elucidate potential differences in demographics, outcomes, and minimally invasive surgery utilization for SCP performed by urology and gynecology. Methods: In our retrospective analysis, sacrocolpopexies were identified using the American College of Surgeons National Surgical Quality Improvement Project database from 2006–2020. Pearson’s chi-square test was performed to test trends in the utilization of MIS in five-year blocks. Frailty… More >
Login
Register
Submit a Paper
Propose a Special lssue
